ETR vs STOK · P/E 28, rev $12.95B vs rev $36.6M
Entergy Corporation (ETR) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. STOK currently screens at market cap $1.88B.
Not investment advice. Open the ETR and STOK stock pages for the full models.
Not investment advice.